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ABSTRACT 
PURPOSE. We tested the hypothesis that near-infrared (NIR) light treatment 
(photobiomodulation) would attenuate bright light damage in the albino rat retina.
METHODS. Young adult Sprague-Dawley (SD) albino rats were raised in dim (5lx) cyclic 
light then exposed to bright (1000lx) continuous light for 24h. Animals were treated with 
670nm light (9J/cm2) using an LED array before, during or after light exposure. Retinas 
were examined for function, structural changes, cell loss, and markers of stress and 
inflammation at 1week and 1month after exposure to damaging white light.  RESULTS. 
Bright light caused photoreceptor-specific cell death in control retinas. Significant up-
regulation of stress and neuroprotective factors, and the presence of activated microglia 
was also noted following light damage. Photobiomodulation profoundly attenuated 
histopathological alterations in all three treatment groups. NIR treatment also abolished 
microglial invasion of the retina and significantly reduced the presence of stress and 
neuroprotectant molecules. Bright light-induced reductions in photoreceptor function were 
significantly ameliorated by photobiomodulation in animals treated before and during light 
damage. Photoreceptor function was initially reduced in animals treated following bright 
light damage but recovered by one-month post exposure. CONCLUSIONS.  NIR
photobiomodulation is protective against bright light-induced retinal degeneration even 
when NIR treatment is applied after light exposure. This protective effect appears to 
involve a reduction of cell death and inflammation. Photobiomodulation has the potential to 
become an important treatment modality to prevent or treat light-induced stress in the 
retina. More generally, it could be beneficial in the prevention and treatment of retinal 
conditions involving inflammatory mechanisms.   
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INTRODUCTION
It has been known since the 1960’s that exposure to excessive light causes 
photoreceptor damage and death1, 2. The severity of damage depends on multiple factors, 
including the intensity or the spectral distribution of the light, the duration of exposure, the 
retina’s history of previous light experience3, 4.  Lesions produced by light damage (LD) are 
characterized by the damage or death of photoreceptors, the disorganisation or loss of 
RPE cells, Muller cell gliosis, the disruption of the outer limiting membrane (OLM), and the 
obstruction of the underlying choroidal vessels. These structural changes are 
accompanied by the accumulation of microglia and lymphocytes in the retinal and 
choroidal vessels, typically in areas with the most severe damage. Once the blood-retina 
barrier (BRB) is disrupted, the invasion of the outer retina by activated microglia becomes 
apparent5-9.
Photobiomodulation is the process, by which specific wavelengths of light are 
absorbed by cellular photo-acceptor molecules resulting in the activation of signalling 
pathways culminating in biological changes in the cell. A typical example would be the 
absorption of light by chlorophyll in plants, initiating photosynthesis. In animals, light 
absorbed by opsins, initiates phototransduction in photoreceptors.  Apart from these 
specialised photoreceptor molecules, there are more than 50 non-specialised photo-
acceptor molecules in mammalian cells. Water, haemoglobin, oxyhaemoglobin and 
melanin all absorb light at a wide range of wavelengths. Between 600-1000nm 
wavelengths however, their absorption curve is at the minimum, providing a ‘window’ for 
other photosensitive molecules to be activated by light10. Cytochrome c oxidase, the 
terminal electron-acceptor in the mitochondrial electron transport chain, is a key 
photoacceptor molecule which has been shown to be activated by far-red to NIR light 
leading to biological changes11, 12.
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The cellular responses to light in the range of far-red to near-infrared photon therapy 
include an increase in metabolic rate, cell migration and proliferation and the production 
and secretion of proteins. Zhang and colleagues have demonstrated changes in gene 
expression profiles in human fibroblasts following exposure to 628nm light for 3 days, 
describing up-regulation in mitochondrial respiratory chain and antioxidant genes, and 
down-regulation in some apoptosis and stress response genes13. Among the proteins, 
some neuro-protective factors, including basic fibroblast growth factor (FGF2) and nerve 
growth factor (NGF) have been shown to be up-regulated14. The use of 670nm light has 
also been demonstrated to protect neuronal cells after cyanide or TTX poisoning12.
In vivo experiments showed improved quality of wound healing in rat skin when 
treated with low-energy ruby laser15 or with Gallium laser at 685 or 830nm light16.
Following spinal cord injury, the use of 810nm light resulted in increased regeneration and 
functional recovery in the rat17. Eells and colleagues showed that 670nm LED light was 
protective to photoreceptors in the methanol-induced degeneration rat model18, others 
demonstrated that NIR light promoted healing after laser lesions in primate retina19.
Clinically, the use of NIR light has been shown to be beneficial in the treatment of 
gingival incisions20, post-transplantational oral mucositis21, radiation ulcers of the skin22,
acne vulgaris dermatitis23. It promoted wound healing24, peripheral nerve repair following 
trauma25-27 and in carpal tunnel syndrome28, 29. NIR treatment is also used in sport 
medicine and rehabilitation to treat acute soft tissue injuries30. It is worth noting that the 
presence of inflammation is common to these conditions.  
Inflammatory events are present in the light-stressed retina5, 6, 9. Moreover, anti-
inflammatory measures such as the administration of microglial inhibitor Naloxone, have 
been shown to reduce light-induced damage in the retina31, 32, indicating that inflammation 
is a critical factor in this model. The purpose of this investigation was to test the hypothesis 
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that 670nm photobiomodulation will ameliorate light-induced retinal damage and modulate 
cellular immune response in the rat retina.
MATERIALS AND METHODS 
Animals
All procedures were in accordance with the ARVO Statement for the Use of Animals 
in Ophthalmic and Vision Research, and with the requirements of The Australian National 
University Animal Experimentation Ethics Committee. Albino Sprague-Dawley (SD) rats 
were born and raised in low (5lx) light levels with a 12h light, 12h dark cycle. Food and 
water were available ad libitum. Once animals reached P100-P120, they were divided into 
6 groups. Three groups were designed to serve as baseline comparisons. In the first group 
animals were not exposed to either NIR or damaging white light (CONTROL group, n=16). 
In the second group, animals were exposed to damaging white light only (LD group, n=16) 
and in the third group they were exposed to NIR light only (NIR CONTROL group, n=16). 
In the remaining groups animals were exposed to damaging bright white light (BL) as well 
as treated with NIR following one of three paradigms described below.  
Light Damage 
Animals (n=19) were transferred to individual transparent cages with food placed on 
the cage floor and water was provided in transparent bottles to avoid shading of the light 
entering the cage. Fluorescent light tubes (18W, Cool White) were placed 200mm above 
the bottom of the cage, so that the light intensity reached 1000lx at the cage floor. Prior to 
light exposure animals were dark adapted overnight. Light exposure started at 9:00AM in 
all experimental paradigms. Animals were exposed to bright light for 24 hours and then 
returned to low light level environment (5lux) to recover for 1 week or 1 month.
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NIR Treatment Paradigms 
Animals were wrapped in a cloth to aid manual handling, and placed under the 
670nm LED array (Quantum Devices, WI, USA). Animals were positioned so that their eye 
level was approximately 2.5cm away from the light source and were exposed to the light 
for 3 minutes at 60mW/cm2. This treatment protocol produced an energy fluence of 9J/cm2
at eye level. The first group of animals were treated with NIR 1x daily on 5 consecutive 
days prior to BL (Pre-conditioned group, n=16). The second group was treated 
immediately after the cessation of BL once a day for 5 days (Post-conditioned group, 
n=16). The third group was treated 1 day prior to BL, then 2x daily during and immediately 
after BL (Mid-conditioned group, n=16). In the NIR Control group animals were treated 
with NIR light once daily for 5 days but were not exposed to BL (NIR Control group, n=16).  
Some animals (n=3) were sham-treated prior to exposure to bright light. They were 
wrapped in towel and kept under an unswitched LED array box for 3 minutes.  
Electroretinography 
The function of photoreceptors was assessed by full-field flash-evoked 
electroretinogram (ERG). Animals were dark-adapted overnight and prepared for recording 
in dim red illumination as described previously33-35.
 A series of single flashes of sufficient intensity to elicit saturated a-wave and b-wave 
responses (44.5cds/m2) was used to record ‘mixed’ responses to assess both rod and 
cone photoreceptor function. As previously reported, the a-wave represents rod function in 
these ‘mixed’ responses36, 37. All animals were recorded prior to the commencement of 
experimental procedures (Baseline recording) and then 1week (n=8/group) or 1 month 
(n=8/group) after BL exposure, regardless of NIR treatment paradigm.  
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Tissue Collection 
Tissue was collected 1 week or 1 month following BL exposure for histological and 
immunohistochemical evaluation. Animals were euthanized with an overdose of sodium 
pentobarbital (>60 mg/kg, intraperitoneal). Eyes were marked at the superior aspect of the 
limbus for orientation, enucleated and immersion-fixed in 4% paraformaldehyde in 0.1 M 
phosphate-buffered saline (PBS) at pH 7.4 for 2 h.  
To prepare for cryosectioning, eyes were rinsed thrice in 0.1 M PBS and left in a 15% 
sucrose solution overnight for cryoprotection. The next day, eyes were embedded in 
Tissue-Tek OCT Compound (Sakura Finetek, Tokyo, Japan), and snap frozen in liquid 
nitrogen. They were cryosectioned in the sagittal plane, to allow a dorsal to ventral 
observation of the retina at 16μm or 60μm using Leica CM1850 cryostat (Leica 
Microsystems, Nossloch, Germany). Sections were mounted on gelatin and poly-L-lysine-
coated slides and dried overnight at 50ºC before being stored at -20ºC.
Histology and Structural Measurements 
Toluidine Blue Staining 
To evaluate structural changes in the retina, Toluidine Blue staining was performed. 
Sections were immersed in 70% ethanol for 5 min for dehydration. The slides were then 
washed with H2O for 5 min before 2 drops of 1% Toluidine Blue were added and left to 
stain the sections for 5 min. Once the sections had taken a purple blue colour, the sections 
were immediately washed with H2O. The stained sections were cover slipped in glycerol-
gelatin medium (Sigma Chemical Co., St. Louis, MO, USA). 
Retinal Thickness Measurements 
To assess retinal thickness, cryosections were labelled with the DNA-specific dye 
bisbenzamide (Hoechst). Sections were thawed at room temperature before washing in 
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70% ethanol for 15 min, followed by a 5 min wash in distilled H2O and two 5 min washes in 
0.1 M PBS. The sections were then incubated for 2 min with bisbenzamide (1:10 000), 
washed in 0.1 M PBS, and cover slipped with a glycerol/gelatin medium. Retinal thickness 
measurements were made on digital images of stained cryosections. At each location, we 
recorded the thickness of the outer nuclear layer (ONL), as well as the thickness of the 
retina, from inner to outer limiting membrane (ILM-OLM). The ratio of ONL and ILM-OLM 
was used for analysis to account for obliquely-cut sections. In at least 4 sections per 
animal, we took 10 measurements from each section, approximately 100μm apart along 
the retina, (a total of 40 measurements per animal). Results from 8 animals from each 
group were averaged and analysed by the statistical method described below. 
OS lengths measurement 
Quantitative analysis of the length of the OS (outer segments) was performed in 
tissues cryosectioned at 60μm labelled with Toluidine Blue. Sections were examined and 
measured using LM-Zeiss Axioskop (Jena, Germany) with Spot CCD camera (MI, USA) 
with a calibrated 40X objective. Images were taken from both superior and inferior retina 
(n=4). Spot CCD software was used to trace the length of the OS with a mean 3 equi-
spaced measurements taken from each area. The average OS length from 4 animals was 
used for statistical analysis.
Immunohistochemistry of Retinal Sections 
Cryosections were labelled with antibodies against glial fibrillary acidic protein 
(GFAP, rabbit polyclonal) (1:700, DAKO, CA, USA), basic fibroblast growth factor (FGF-2, 
mouse monoclonal) (1:200, Upstate Biotechnology, USA), ciliary neurotrophic factor 
(CNTF, goat polyclonal) (1:200, R&D Systems, MN, USA), ionized calcium binding adaptor 
molecule 1, (IBA1, mouse monoclonal) (1:500, Abcam, MA, USA) and CD68, also known 
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as ED-1, (mouse anti-rat monoclonal, 1:200, Millipore, CA, USA) using a protocol 
previously described35. Briefly, sections were blocked with 10% normal goat serum for 1 h 
before being incubated with primary antibody for 24 h at 4ºC. Sections were treated with 
an antibody to either rabbit IgG conjugated with Alexa Fluor 594 or mouse IgG conjugated 
with Alexa Fluor 488  (1:1000, Molecular Probes, OR, USA) for 24 h at 4ºC before 
incubation with the DNA-specific dye bisbenzamide (1:10 000) for 2 min.
RNA Isolation and cDNA Synthesis  
Retinas were collected and stored in RNAlater® (Ambion, Applied Biosystems, 
Foster City, CA) overnight at 4ºC. RNA isolation was then performed using TRIzol 
Reagent (Invitrogen, Carlsbad, CA).  The retinas were homogenised in 1.5ml tube with 
200μl of Trizol on ice, followed by further addition of 660μl Trizol and 160μl chloroform. 
The tube was vortexed for 20s, allowed to stand for 7 minutes at room temperature and 
then centrifuged at 13,000x g for 10 minutes at 4ºC. The resulting supernatant was 
subsequently removed and transferred into a clean 1.5ml tube with half of its volume of 
100% absolute ethanol. The tube with its content was vortexed briefly prior to performing 
purification and DNAse treatment steps, as outlined in the RNAqueous-micro kit protocol 
(Ambion, Applied Biosystems Foster City, CA). The purified and DNAse-treated RNA was 
quantified on a spectrophotometer (ND-1000; Nanodrop Technologies, Wilmington, DE) 
followed by analysis of its integrity using a bioanalyser (2100 Bioanalyzer; Agilent 
Technologies, Santa Clara, CA). The synthesis of cDNA was achieved by reverse 
transcribing 1μg of total RNA using the Superscript® III Reverse Transcriptase First Strand 
Synthesis kit following the prescribed manufacturer’s protocol (Invitrogen Life 
Technologies, Carlsbad, CA).
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Real Time Quantitative Polymerase Chain Reaction (RT-qPCR) 
Validation of the changes in expression of stress-related Gfap and protective Fgf-2
genes were determined by RT-qPCR using Taqman® probe IDs Rn00566603_m1 for Gfap
and Rn00570809_m1 for Fgf-2, combined with the Gene Expression Master-Mix (Applied 
Biosystems, Foster City, CA) with the use of StepOne Plus qPCR machine with the 
StepOne software v2.1 (Applied Biosystems). Glyceraldehyde 3-phosphate 
dehydrogenase (Gapdh) was used as a reference gene. To account for variability, Taqman 
amplification assay was performed in duplicates (individual sample variability) with 
triplicate biological samples to account for individual animal differences. The fold changes 
were determined using comparative cycle threshold (Ct; delta-delta ct).
Microscopy
Images of the immuno-labelled retinal sections were obtained using Carl Zeiss 
confocal microscope (Germany) and LM Zeiss Apotome (Germany). Only samples that 
were processed and imaged concurrently were used for analysis. During image collection, 
the photomultiplier settings were kept constant to allow more accurate comparison of 
protein levels. 
Statistical Analyses 
Data were analyzed using a two-tailed Student’s t-test with P<0.05 considered to 
represent a statistically significant difference. All data are presented as the mean ±1 SEM.
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RESULTS
NIR photobiomodulation preserved retinal structure in all 3 treatment 
paradigms
Figure 1A depicts retinas of animals not exposed to BL nor treated with NIR (control), 
animals exposed to BL (LD), animals not exposed to BL, but treated with NIR (NIR 
treated), and animals exposed to BL and treated with NIR following one of the three 
treatment paradigms (Precon, Midcon, Postcon). Histological labelling of cryosections with 
Toluidine blue showed that exposure to BL led to structural damage in the outer retina (Fig 
1A, B). The severity of the damage was uneven along the retina. One week after light 
exposure, an area of high-density cell death was detectable 1-2mm supero-temporal to the 
optic disc (depicted in Figure 1A, C) that exhibited significant thinning of the ONL in BL-
exposed, non-treated retinas. In this area both inner (IS) and outer segments (OS) were 
lost and only a few rows of photoreceptors remained. The retina was severely distorted, 
the outer limiting membrane and the retinal pigment epithelial cell row were disrupted and 
the BRB appeared to be compromised (Fig 1A & B ‘LD’). Similar pattern and severity of 
structural damage was observed in LD-exposed retinas with sham NIR treatment. 
Quantitative analyses indicate that there were no significant differences in the OS lengths 
and ONL thickness between the non-treated and sham NIR-treated retinas with LD 
exposure. In areas, outside this “hot spot”, the retinal changes were minor, limited to the 
shortening and distortion of the photoreceptor outer segments (not shown). These images 
demonstrate that NIR treatment alone did not cause any structural alterations in the retina. 
In light-exposed retinas treated with NIR, the preservation of the ONL was evident, 
whereas the IS/OS were only slightly shortened and mildly disrupted in all three treatment 
paradigms.
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The cumulative effect of photoreceptor cell death was assessed by the measurement 
of the outer nuclear layer (ONL) thickness (Fig 1C). Toluidine blue staining was used to 
detect surviving cells 1 week after BL exposure (Fig 1A). The panel depicting a BL 
exposed non-treated retina shows a severe disruption and reduction of the photoreceptor 
population in the hot spot area (Fig 1A, B ‘LD’). NIR treatment of BL-exposed retinas 
profoundly attenuated photoreceptor cell loss in all treatment paradigms. Figure 1C shows 
the average ONL thickness along the retina in 8 animals in each treatment group. BL 
exposed, non-treated retinas showed a significant thinning of the ONL in all areas of the 
retina; in the inferior retina, there was a 25% loss, while in the superior retina there was a 
50% reduction of thickness, and in the hot spot area ONL thickness was reduced by 75% 
compared to controls.  NIR-treated BL exposed animals exhibited a small decrease in ONL 
thickness. However, ONL thickness in NIR-treated BL-exposed animals was not 
statistically different from values measured in Control animals.
Figure 1D shows the average OS length values along the retina for 8 animals in each 
group 1 week after BL exposure. In BL exposed animals, OS length was close to 60% 
shorter in the inferior retina when compared to corresponding areas of control retinas, and 
70-75% shorter in the penumbra of the hot spot in the superior retina compared to 
controls, with a complete loss of the IS/OS in the hot spot area. NIR treatment ameliorated 
OS damage in BL exposed animals. In the pre-conditioned group OS lengths were not 
significantly different from control animals not exposed to BL. Retinas in the mid-
conditioned group exhibited an approximately 25% decrease in OS length compared to 
control. In the post-conditioned group, OS length was reduced to 50% of non-BL control 
values. In the hotspot region, the length of OS dropped by around 60%, however there 
was no complete loss of OS at any of the retinas in this group.
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 NIR photobiomodulation attenuated LD-induced retinal functional loss
Figure 2 summarises the changes in photoreceptor function 1 week after exposure to BL. 
Panel A shows typical recordings of selected animals from each group. Dotted lines show 
baseline recording and solid lines show post-BL recordings of the same animals. Grey 
lines represent non-treated BL-exposed animals, black lines represent NIR treated light-
stressed retinas 1 week post-exposure. The figure also demonstrates that there was a 
significant loss of retinal function following BL exposure in preconditioned and 
midconditioned animals,  however, the NIR treated animal exhibited a more moderate loss 
compared to the non-treated animal, showing significantly better photoreceptor function 
when compared to LD group. In the post-conditioned group, at 1 week after BL, 
photoreceptor function of NIR treated animals was indistinguishable from that of non-
treated LD animals. 
Figure 2B shows the average a-wave amplitudes assessed by the dark-adapted full-field 
flash ERG in 8 animals in all experimental groups. Changes were expressed as the ratio of 
amplitudes measured 1 week after BL exposure and amplitudes measured pre-exposure 
on the same animal, thus a value of 1 represent no change. NIR treatment alone did not 
have a significant effect on photoreceptor function. Retinas, exposed to BL but not treated 
with NIR showed a significant loss of photoreceptor function, decreasing to less than 20% 
of baseline value 1 week after BL exposure. In the NIR treated groups the effect of BL on 
photoreceptor function varied. In the pre-conditioned group, the amplitude of a-wave 
decreased to 56% of baseline values 1 week after BL. Although the decrease from 
baseline was significant, the post LD values of the a-waves in the NIR pre-conditioned 
group were significantly greater than that measured in the LD group.  In the NIR mid-
conditioned group, photoreceptor function was reduced to 60% of baseline values 
indicative of photoreceptor protection compared to the LD group. The NIR post-
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conditioned group exhibited significant photoreceptor dysfunction relative to baseline 
recordings.  In this group, there was a 70% reduction in the a-wave amplitude at 7 days 
post LD. The relative a-wave amplitudes of the NIR post-conditioned group were not 
significantly different from those measured in the non-treated BL group, thus NIR post-
conditioning did not offer functional protection for photoreceptors at this early stage.   
 The effects of NIR treatment on the functional response downstream from the 
photoreceptors was also assessed by measuring the b-wave amplitudes in NIR-treated 
retinas 7d after LD exposure. The relative b-wave amplitude was analysed and presented 
in the same manner as the relative a-wave values were assessed (please refer to previous 
section). As shown in Figure 2C, b-wave response in the non-treated LD retinas was 
reduced by 73% from the baseline value. There was a slight variation observed in 
responses in b-wave amplitudes from the retinas in NIR-treated groups. The reduction of 
b-wave response in the Midconditioned retina was only 20% while the Precon group 
showed 30% loss of b-wave amplitude. Conversely, the Postcon retinas showed the most 
severe reduction, b-wave response reaching 30% of control values, a level similar to the 
non-treated LD retina. There was no change observed in the NIR-treated only control.  
NIR photobiomodulation mitigated retinal stress and modulated 
neuroprotectant regulation
We observed the levels of two known retino-protectant proteins, ciliary neurotrophic 
factor (CNTF) and basic fibroblast growth factor (FGF-2) and the glial fibrillary acidic 
protein (GFAP), a known stress marker, following light exposure and assessed the effects 
of NIR on these protein levels. Ciliary neurotrophic factor was not detectable in the normal 
retina. Treatment with NIR alone did not change the pattern of protein expression and did 
not increase its concentration. Following light exposure, there was an up-regulation of 
protein levels in astrocytes, and Muller cells, exhibiting a strong, punctate labelling along 
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the Muller cell processes. In the penumbra of the hot spot, CNTF labelling in the retinal 
tissue was limited to the OS’s of photoreceptors. In animals exposed to BL and treated 
with NIR, CNTF protein up-regulation varied. The least up-regulation was found in the 
preconditioned group where CNTF was barely detectable in the retinal tissue. Retinas of 
the mid-conditioned group showed stronger presence of the protein, localised in the OS’s. 
Retinas of the postconditioned group demonstrated the strongest up-regulation in the 
photoreceptor OS layer and the astrocytes, where the labelling showed similar pattern and 
intensity found in the penumbra region of the control retina (Fig 3D).
GFAP labelling was limited to astrocytes, in the innermost layer of the retina in 
healthy retinas. In control animals and in animals treated with NIR alone, GFAP labelling 
showed normal pattern as demonstrated in Fig 3C in red. In light-stressed retinas, labelling 
of Muller cell processes became apparent. In non-treated, BL-exposed retinas a strong up-
regulation of GFAP was detectable in astrocytes and in Muller cells 1 week after light 
exposure. Labelling was most prominent in the hot spot, where the entire Muller cell 
became GFAP+ from the inner limiting membrane to the outer retina and the subretinal 
space, where activated Muller cells started to form glial scar (Fig 3C, red). In regions 
outside the hot spot, labelling was present in the Muller cells but was more muted (not 
shown).
In the NIR treated animals, in all three treatment paradigms, GFAP labelling was up-
regulated and was present in the Muller cells, but localised to the inner layers of the retina 
predominantly, not reaching the outer processes of Muller cells. However, there was a 
noticeable gradient between treatment paradigms, with a more moderate change in the 
pre-conditioned and mid-conditioned animals, and a more significant up-regulation in the 
post-conditioned animals, though even here, the levels of GFAP regulation did not reach 
the levels found in non-treated BL-exposed animals. 
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FGF-2 is normally present in retinal macroglia (Muller cells and astrocytes), ganglion 
cells and RPE, but not in photoreceptors38-40. In control retinas, FGF-2 labelling was 
prominent in the Muller cell bodies, in the INL (Fig 3C, green). Following exposure to 
damaging light, FGF-2 protein was up-regulated in the ONL. This up-regulation was noted 
along the retina, but was most prominent in the hot spot. 
NIR treatment alone did not cause a change in FGF-2 protein expression. In animals 
from the pre-conditioned group, FGF-2 up-regulation was not detected in the ONL. In the 
mid-conditioned group only a moderate increase in FGF-2 labelling was detectable in the 
INL and ONL of the hot spot region, but not outside this area. There was a significant up-
regulation of FGF-2 protein in the ONL. In the post-conditioned group, similar to the one 
seen in control light-exposed retinas.
To validate the expression of the FGF-2 and GFAP proteins described in the 
previous sections, the regulatory effects of NIR treatment in Gfap and Fgf-2 genes were 
assessed quantitatively 1 week post BL exposure using RT-qPCR. We observed an 
increase in gene expression of both Fgf-2 and Gfap of both light exposure and NIR treated 
retinae. Figure 3A shows that in the non-treated LD retina, there was a 5.8-fold increase in 
the expression of Fgf-2 gene. However, the NIR-treated groups exhibited varied levels of 
upregulation. There was a 3-fold increase in the Precon, 6.2-fold in Midcon and Postcon 
groups generated an 8.7-fold upregulation. When compared to the non-treated LD retina, 
Precon group showed a significant difference. There was no change observed in the level 
of expression of Fgf-2 gene in the NIR-treated control. Similar pattern of gene expression 
was observed in the stress-related Gfap gene following LD exposure and NIR treatment 
(Figure 3B). An increase of 12.2-fold was seen in the non-treated, light-stressed retina 
(LD) while the upregulation in Precon was slightly down to 8.9-fold, and a more modest 
17
   
increase of 12-fold in the Midcon-treated retinas and 21.8-fold in the Postcon group 
(Figure 3B). No fold change was observed in the NIR-treated control group.  
NIR light treatment mitigated light-induced inflammatory reaction  
Antibodies against ED-1, macrophage and monocyte marker and IBA1, a microglia 
marker were used to assess the presence of inflammatory cells in the light-stressed retina 
(Figure 4). In control non-BL exposed non-treated animals, very few monocytes were seen 
and those present were limited to the choroidal vessels. In BL-exposed retinas, monocytes 
were detectable in both the choroidal and retinal vessels in the area of the incipient hot 
spot immediately after BL exposure. By 1 week post-exposure, a breakdown of the blood-
retina barrier was apparent in the hot spot area, where monocytes invaded the retinal 
tissue and were present in the severely damaged ONL (Figure 4A). NIR treatment alone 
did not change monocyte numbers in the choroidal, retinal vessels or in retinal tissue. In 
BL-exposed, NIR-treated animals, there was a slight increase in monocyte numbers both 
in retinal and choroidal vasculature, however this increase was significantly less than the 
level seen in light-exposed control animals. In addition, retinal invasion of 
macrophages/monocytes was not detectable in any of the treated animals (Figure 4A). 
Quantitative assessment of monocyte population was performed by counting ED-1+ 
profiles in different layers of the retina and in the choroid of 4 animals in each experimental 
group and summarised in the graph (Figure 4B). Light exposure caused a significant 
increase in the presence of monocytes in the choroid and inner retina as well as in the 
severely damaged ONL of the hot spot. Although, there was a slight increase in the 
number of monocytes both in the choroidal and retinal vessels in the NIR treated light-
stressed retinas, this increase was significantly less than in non-treated, BL exposed 
retinas. Moreover, there were no ED-1+ profiles present in the retinal tissue in any of the 
NIR-treated retinas. 
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To establish the source of the activated microglia present in the retina, IBA1 labelling 
was performed (Figure 4C). This antibody can detect a protein specifically expressed in 
microglia and macrophages and to discriminate resting and activated microglia. Figure 4C 
shows the distribution of microglia in the retina. In control retinas, microglia present in 
choroidal and retinal vessels exhibited a ramified appearance, typical to resting microglial 
cells. After exposure to BL, the majority of microglial cells that were detected in the retina 
showed amoeboid configuration, typical to cells in an activated phase. When we quantified 
resting and activated microglia in the retina, as shown in Figure 4D, we found that NIR 
treatment alone did not change the numbers or the activity status of microglia when 
compared to control. Following exposure to BL, the number of microglia did not increase 
significantly, however, the ratio of activated cells increased significantly, reaching 85% of 
all microglia present. In the preconditioned and midconditioned groups the ratio of 
activated cells increased significantly, though it only reached 66 and 57% respectively, of 
the total microglial population detected. In the postconditioned group, the number of 
microglial cells and the ratio of activated cell within their population were similar to the non-
treated BL-exposed group.     
Long-term effects of NIR treatment on the light-stressed retina 
To gauge the extent of the protective effect of NIR treatment, we assessed retinas 1 
month after BL exposure. Figure 5A summarises photoreceptor function in all 6 
experimental groups, expressed as the average of ratio of post- and pre-exposure 
amplitude values for each animal, thus the value of 1 means no change. Again, NIR 
treatment alone showed no significant effect on photoreceptor function. In the light 
exposed but non-treated group, the average a-wave amplitude (top panel) fell to less than 
15% of the pre-exposure value, which was not significantly different from values found at 
the 1 week timepoint. The preconditioned group showed a mild improvement from the 1 
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week average value of 56% to 65% by 1 month postBL exposure. The midconditioned 
group showed no further improvement from the values measured at the 1 week post-
exposure time, it remained close to 60%. However, when post-conditioned animals were 
allowed to recover for 1 month after BL exposure, there was a significant recovery in their 
photoreceptor function. While the average a-wave amplitude was 30% of baseline values 
at the 1 week time point, by 1 month postBL, the average value rose to 58% that was 
reaching the levels of the other 2 NIR treatment paradigm groups, becoming significantly 
greater than non-treated, BL damaged retinas.
The long term effect of NIR on the function of inner retinal cells was evaluated by 
measuring the b-wave amplitudes of NIR-treated animals 1 month after bright light 
exposure.  As demonstrated in Figure 5A (bottom panel), the b-wave amplitude response 
from non-treated, LD-exposed animals showed further reduction from the values detected 
at 1 week postLD, reaching 10% of baseline values. Conversely, the b-wave responses in 
the NIR-treated groups showed no further loss of function. In the preconditioned and 
midconditioned groups, the values of the responses remained stable from the 1 week 
postLD levels. However, there was a significant improvement observed in the 
postconditioned group at 1 month after LD exposure. The b-wave amplitudes in this group 
reached 82% of baseline values, representing over 50% recovery from the 1 week postLD 
levels. Treatment with NIR alone did not cause any significant change in the photoreceptor 
function.
Figure 5B demonstrates retinal structure in the hot spot area, following 1 month of 
recovery. In the non-treated, light-exposed retina, the ONL was obliterated and RPE 
disrupted. RPE and ONL were both present in retinas treated with NIR, albeit the 
photoreceptor layer was thinner when it was compared to non-challenged control retinae. 
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The outer segments showed organised appearance, compared to the disturbances 
observed in the midconditioned and postconditioned groups 1 week postBL. 
Outer segment lengths measurements (Figure 5C) showed that, there was a total 
loss of OS’s in a wide area of the BL exposed retina, spanning over 5mm length and 
centered by the original hot spot area. In the NIR-treated groups, the length of the OS’s 
was reduced compared to control retinas, but was significantly longer compared to the 
non-treated light-exposed retina. Moreover, OS’s were present along the retina in all three 
treatment groups.
To assess the cumulative effect of light and NIR treatment on the photoreceptor 
population, we measured the ONL thickness in all groups (Figure 5D). In the LD group, 
photoreceptor cells were lost in a large, 4mm long area in the superior retina extending 
from the original hot spot area, whereas, there was a more moderate thinning of the ONL 
in the rest of the retina. The ONL thickness did not change greatly from the 1 week time 
point, in the NIR-treated retinas. 
DISCUSSION 
Bright white light induced retinal damage  
Our findings in retinas exposed to bright continuous light for 24 hours are consistent 
with those reported in the literature. Three major events, characteristic of light-induced 
retinal damage are 1.) wide-spread death of photoreceptors, 2.) degeneration of pigment 
epithelial cells and 3.) reduction or total extinction of the ERG2,41. Rapp and Williams 
reported on the variable sensitivity of retinal regions to light42. Typically, the superior 
central portion of the retina shows a higher sensitivity than other areas9, 42-44. This region 
has been shown to contain the highest concentration of ganglion cells45, and 
photoreceptors in this area possess longer outer segments46, which renders this part of the 
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retina the functional area centralis in the rat. Recently we reported that in the light damage 
paradigm used in this study, the most severe, irreversible damage occurred in this central 
area of the retina. Moreover, severe, acute damage became the centre of a progressive 
degeneration9.
670nm photobiomodulation induced retinoprotection 
This study demonstrated that 670nm photobiomodulation ameliorates the damaging 
effects of bright continuous light on the retina. Treatment with 670nm light before, during or 
even after exposure to BL led to a significant reduction in photoreceptor cell death and 
prevented the severe disruption of the outer retina and the RPE. Photobiomodulation 
prevented the obliteration of the choroidal vascular network, thus assuring the 
maintenance of the blood-retina barrier. Photoreceptor structure was maintained in the 
treated groups, albeit the outer segments shortened, misaligned and some small vacuoles 
were present in the hot spot area. These changes however were reversible, because after 
a period of recovery in dim light, OS’s became more organised and longer than at the early 
stages after light-stress. Our findings in the preconditioned group somewhat agreed with 
those reported by Qu et al47. Although they showed a reduced rate of photoreceptor loss 
and better retinal function in the NIR-treated animals in their light damage paradigm, they 
were not able to avoid the development of a hotspot that could be a source of long-term 
degeneration.
Photobiomodulation also reduced cell stress and inflammatory reaction in the retina. NIR 
treatment mitigated the up-regulation of GFAP in Muller cells, a known stress marker. It 
has also reduced the number of microglial cells in the retinal and choroidal vessels. 
Though it did not prevent the activation of microglia, it significantly reduced the number of 
activated cells and prevented their invasion into the outer retina.  
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In conjunction with the maintenance of outer retinal structure, photoreceptor cell function 
was also preserved. In animals treated before (pre-conditioned) or during (mid-
conditioned) BL, photoreceptor function was significantly better than non-treated controls 
at 1 week post-exposure and that function was maintained at the 1 month post-exposure 
time. In animals treated after BL (post-conditioned), photoreceptor function was 
significantly reduced 1 week post-exposure. However, by 1 month post-exposure, 
photoreceptor function recovered in this group as well, indicative of a protective effect 
similar to the other two treatment paradigms. In contrast, photoreceptor function remained 
diminished in the non-treated BL-exposed animals.
The apparent discrepancy between the state of retinal structure and its function in the 
postconditioned group prompted us to investigate possible mechanisms responsible for 
the reduction of photoreceptor function without apparent major structural damage. One 
such mechanism may possibly be through the up-regulation of neuroprotectants, such as 
ciliary neurotrophic factor (CNTF), basic fibroblast growth factor (FGF-2). Earlier studies 
have shown that both of these proteins are effective retinoprotectants48-51. It has also been 
demonstrated, that both of these factors have a direct effect on retinal function49, 52-55. In 
our case, both CNTF and FGF-2 were up-regulated in the light-exposed non-treated 
group, similarly to earlier published data56. The up-regulation of both factors has been 
related to the reduction in retinal function52, 53 and thus they could be factors in the 
functional changes observed in our animals. In the NIR treated animals, we were able to 
detect the up-regulation of CNTF in the photoreceptor OS layer and FGF-2 protein in the 
ONL at varying degree that  could explain the difference in functional response in the three 
treatment groups. The most severe loss of function correlated with the highest level of 
CNTF and FGF-2 protein up-regulation. It has been shown that the neuroprotectant  up-
regulation following an insult is only temporary52, and once the stress is removed, protein 
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levels are gradually reduced. It is possible, that the transient loss of function in the post-
conditioned retinas are due, at least partly, to the increased presence of neuroprotectants 
in the outer retina, which allowed the survival and recovery of photoreceptors. Once the 
crisis was over, and their presence was no longer necessary, the level of these factors 
reduced, allowing the recovery of retinal function. In retinas exposed to damaging light, but 
not treated by 670nm photobiomodulation, the white light induced damage of 
photoreceptors and RPE might possibly have overwhelmed the retinoprotective system, 
and despite the presence of these factors, a large number of photoreceptors were lost and 
thus retinal function could not recover. 
Potential Mechanism of Photobiomodulation 
Photobiomodulation, or low energy photon irradiation by far-red/near infrared 
(FR/NIR) light using low energy lasers or LED arrays, collectively termed 
“photobiomodulation”, has been applied clinically in the treatment of soft tissue injuries and 
acceleration of wound healing for more than 30 years57. Recent studies demonstrated that 
low energy laser and LED NIR penetrates diseased tissues including the heart, spinal cord 
and brain58, 59. NIR treatment has been documented to improve recovery from ischemic 
heart injury58, attenuate degeneration in the injured retina and optic nerve58, 60 and improve 
recovery in experimental and clinical stroke59, 61, 62.  Clinical trials in the treatment of 
radiation-induced mucositis and stroke have demonstrated therapeutic efficacy of 670 nm 
and 830 nm light administered at doses ranging from 3 - 6 J/cm2. Thus, existing data 
demonstrate the therapeutic potential of NIR light. 
The cytoprotective action spectrum of FR/NIR light corresponds with the cytochrome 
oxidase absorption spectrum57, 63. Recent studies have shown that NIR irradiation 
produces redox alterations in the cytochrome oxidase molecule resulting in the activation 
of intracellular signaling cascades which culminate in improved mitochondrial function and 
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increased synthesis of cytoprotective factors12, 57, 59, 60, 64-68. Others showed increased 
tissue concentrations of antioxidants (glutathione, mitochondrial superoxide dismutase 
[SOD2]) and cytoprotective growth factors69. Recently, we reported on gene regulatory 
effects of NIR treatment in the normal and light-stressed retina70. Our findings showed NIR 
had an effect on many intracellular pathways, among others a direct effect on antioxidant 
protection and the downregulation of a chemokine, ccl2, that has been shown to induce 
leukocyte recruitment and activation71. Present study provided further evidence of the 
direct effect of NIR light on inflammation, by showing a reduction of monocyte recruitment 
and microglia activation in treated eyes.
Our earlier genechip study suggests, that NIR has no direct effect on the regulation 
of neuroprotectants, such as fgf-2 or cntf genes. This study confirmed the negative 
correlation between structural protection and FGF-2 regulation, that suggests that 
photobiomodulation does not act through neuroprotective pathways directly, but possibly 
at a point more upstream, thereby preventing, rather than mitigating cell damage.  
More interestingly, our previous wide-scale gene analysis showed that NIR 
upregulated many noncoding RNAs (ncRNA)70. That could explain the lack of any 
apparent effect of the NIR treatment on the healthy, non-challenged retina. Further 
research is necessary to understand the exact role these ‘non-coding’ sequences may 
play in the retina, but one possible hypothesis presents itself, that while they don’t have 
any apparent effect on healthy tissue, they may act as a pre-conditioning event that allows 
the modification of the regulation of potentially damaging genes in the presence of stress 
stimuli.
Clinical implications 
The use of photobiomodulation remains controversial as a consequence of an 
incomplete understanding of its mechanisms of action, differences in treatment paradigms, 
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wavelengths and  mixed results in both the laboratory and clinic72. In addition, it is hard to 
assess the efficacy of the treatment in the clinic, due to the lack of appropriately controlled 
and blinded clinical trials. Photobiomodulation is used in many types of tissues targeting a 
variety of conditions using different wavelengths, dose and light sources (laser vs. non-
coherent light), which makes standardisation near impossible.  Despite the controversies, 
many successes have been achieved in a few areas clinically, specifically in three areas: 
1) wound healing, 2) the relief of inflammation and 3) the reduction of neurogenic pain.
Present data suggest that treatment with 670nm red light can lead to significant 
protection of the retina from light-induced damage. This treatment has the potential to 
reduce the adverse effects of bright light exposure moreover this non-invasive therapeutic 
modality has considerable promise for the treatment of retinal degenerative disorders and 
ocular inflammatory disease conditions. 
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FIGURE LEGENDS 
Figure 1.
(A) Representative images of Toluidine Blue labelled sections from the superior 
region of the retina. In control retina, the cells are distinctly arranged in respective layers 
and outer segments are neatly organised. In LD and Sham NIR LD sections, severe 
disruption of the outer retina and diminished photoreceptor population are observed. No 
gross structural changes are seen in any of the NIR-treated groups. White line indicates 
how ONL thickness was measured. (B) Higher magnification images of retinal sections 
labelled with Toluidine blue, focussing on the outer segments, the adjacent pigment 
epithelium and the choroid. Thin white line highlights the OLM, thick white vertical line 
indicates how OS length was measured. The white horizontal trace indicates the intact 
outer limiting membrane. (C) Graph summarising the quantitative analysis of 
photoreceptor population, assessed by measuring the thickness of the ONL and the full 
retina (n=8). (D) Graph summarising quantitative analysis of OS lengths in the different 
groups (n=8). To counter for variations in cutting angles, the ratio of the two measures 
were depicted in this graph. The black solid lines in C and D correspond to the area of the 
retina with statistical significance.  ** Statistically significant differences (P < 0.05) 
compared to control groups. Scale bar represents 25 μm. 
Figure 2. 
(A) Representative dark-adapted scotopic ERG recordings showing traces of a-wave 
responses. Dotted lines represent ERG recording prior to treatment and/or light exposure, 
solid lines represent ERG recording after light exposure and NIR treatment of the same 
animals. Photoreceptor function was significantly reduced in non-treated LD retina (grey 
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solid lines) following exposure to BL. Functional recovery was observed in Precon and 
Midcon but not in Postcon group (black solid lines). (B) Analysis of the relative 
preservation of the a-wave response of NIR-treated groups against the non-treated, LD 
retina. Functional changes were measured by taking the ratio of post damage plus 
treatment and the baseline values of a-wave amplitude in all animals in each group (n=8). 
(C)  Analysis of the relative b-wave amplitudes of dark-adapted ERG responses in treated 
and non-treated SD rat retinas prior to (baseline recording) and after 7 days after exposure 
to bright light. Changes in b-wave amplitudes were analysed by taking the ratio of post 
damage plus treatment and the values from the baseline recordings in all animals in each 
group (n=8). The bars indicate the mean + SEM. **Statistically significant differences (P < 
0.05) compared to Control group. 
Figure 3.
(A, B) Validation of the differential expression of Fgf-2 and Gfap genes using 
quantitative RT-PCR. cDNAs from NIR-treated and non-treated BL-exposed SD retinas  
were used for quantitative expression analysis and Gapdh was the reference standard. 
The level of expression of these genes in all groups was compared to the control group, 
and the value was generated for a fold change in expression. A fold-change of 1 indicates 
no change (dashed line), a fold change >1 shows upregulation and <1 indicates 
downregulation.  The bars indicate the mean +SEM. **Statistically significant differences 
(P < 0.05) compared to LD group. 
(C) Retinal stress status of the treated and non-treated animals after 7 days of 
exposure to damaging levels of light through double immunolabelling with the stress 
marker GFAP (red) and the neuroprotective protein FGF-2 (green). Treatment with NIR 
mitigated the up-regulation of both proteins in all three treatment groups. There was a 
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gradient in the immunoreactivity for both proteins in the NIR treatment groups, with the 
strongest up-regulation in the Postcon group.
(D) Images of retinal sections labelled with CNTF antibody (red), showing a strong 
up-regulation in the inner retina (astrocytes) and in the remnants of ONL in the hotspot of 
LD retinas. In the penumbra, a few m away, CNTF protein presence was more moderate 
and limited to the OS layer. A gradient of immunoreactivity in OS and GCL is 
demonstrated in the 3 NIR-treated groups. The blue labelling is bisbenzamide, a DNA-
specific stain, indicating the nuclear layers of the retina. Scale bar represents 25 μm. 
Figure 4. 
(A) Representative images of retinal sections, from the superior retina, labelled with 
the marker for macrophages, ED-1 (red). White arrows point out ED-1+ cells in the NIR-
treated retinas. (B) Graph summarising the quantification of macrophages present in the 
choroidal or retinal vasculature and the retina. ED-1+ cells were sparsely present in the 
choroid of the control normal retina but absent in the ONL and inner retina. One week 
following exposure to LD, a significant increase in the number of ED-1+ cells was 
observed in the choroidal and inner retinal vasculatures including an apparent tissue 
invasion. Following NIR treatment, the increase in the number of ED-1+ cells was more 
muted and localised only to the choroid and retinal vasculatures in all treated groups as 
indicated by the white arrows. (C) Representative images of retinal sections labelled with 
IBA1 (green), showing the resting and activated retinal microglial cells. In control retina, 
the resting microglia, identified by the ramified morphology (inset first panel in C) were 
present along the inner retinal vasculature only. After 7d of exposure to BCL, there was an 
increase in the number of microglia that showed amoeboid morphology (inset, second 
panel is C) in the ONL and retinal vasculatures suggestive of its activated form. Following 
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NIR treatment, activated cells were still present, but they were limited to the inner retinal 
vessels of all treated paradigms and not in the tissue. (D) Graph showing the number of 
microglial cells present, distinguishing between resting and activated cells. **Statistically 
significant differences (P < 0.05) compared to control groups. Scale bar represents 25 μm. 
Figure 5.
(A) Relative a-wave (top panel) and b-wave (bottom panel) amplitudes analyses 
before and after 1 month of NIR treatment and BCL exposure. (B) Representative images 
of retinal sections stained with Toluidine Blue at 1 month recovery. The white vertical line 
indicates the thickness of the ONL and the black slanted line represents the outer 
segments length was measured. (C-D) Quantitative analyses of the OS length and ONL 
thickness sampled across the retina from the inferior to the superior edge (n=8). The bars 
indicate the mean +SEM. **Statistically significant differences (P < 0.05) compared to 
control groups. Scale bar represents 25 μm. 
35
   
36
   
37
   
38
   
39
   
